Lehman & Derafelo Financial Resources’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AWA
Lehman & Derafelo Financial Resources's PFE Position: Q4 2022 in Review
Lehman & Derafelo Financial Resources reduced its Pfizer (PFE) stake by 0.52% in Q4 2022, selling an estimated $53.5K and leaving 211,824 shares worth $10.9M. The position accounts for 3.22% of the portfolio, ranked #6.
Lehman & Derafelo Financial Resources first reported a position in PFE in Q4 2018 and has held it in 17 quarters since. The position peaked at $12.7M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Lehman & Derafelo Financial Resources held 211,824 shares of Pfizer worth $10.9M as of Q4 2022.
- Lehman & Derafelo Financial Resources sold 1,115 Pfizer shares in Q4 2022, an estimated $53.5K.
- Pfizer made up 3.22% of Lehman & Derafelo Financial Resources's portfolio in Q4 2022, its #6 holding.
- Lehman & Derafelo Financial Resources first reported a position in Pfizer in Q4 2018 and has held it in 17 quarters since.
- Lehman & Derafelo Financial Resources's Pfizer position peaked at $12.7M in Q4 2021.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.